GO:0003199 endocardial cushion to mesenchymal transition involved in heart valve formation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003199 describes the process by which endocardial cushion cells lose polarity, detach, degrade basement membrane and become migratory mesenchymal cells that build cardiac valves.
• This transition is a specialized endothelial-to-mesenchymal transition (EndoMT) essential for heart valve formation and outflow tract septation.
• Signaling pathways including Notch, TGF-beta, BMP and Wnt, together with transcription factors such as Snail, Slug and Twist, control the transition.
• Hemodynamic forces and microRNAs (e.g., miR-23b, miR-199a) modulate the timing and extent of the transition.
• Defects in this process cause congenital heart valve anomalies, including bicuspid aortic valve and atrioventricular valve abnormalities.
• CRISPR-based knockout, knock-in and overexpression models enable causal testing of candidate genes in this pathway.
Description
GO:0003199, endocardial cushion to mesenchymal transition involved in heart valve formation, is a biological process that converts endocardial cushion cells into migratory mesenchymal cells that populate the developing cardiac valve primordia. This transition is a specialized form of endothelial-to-mesenchymal transition (EndoMT) and is a prerequisite for the formation of the atrioventricular and outflow tract valves. The process is tightly regulated by signaling pathways and transcription factors, and its disruption leads to congenital heart valve malformations. Researchers study GO:0003199 to understand the molecular basis of valve development and to identify therapeutic targets for valve disease.
endocardial cushion to mesenchymal transition involved in heart valve formation At A Glance
| GO ID | GO:0003199 |
|---|---|
| GO term | endocardial cushion to mesenchymal transition involved in heart valve formation |
| Ontology | biological_process |
| Synonym | endocardial cushion to mesenchymal transition involved in valve formation |
| Major function | Conversion of endocardial cushion cells into migratory mesenchymal cells that contribute to cardiac valve formation |
| Related process | Endothelial-to-mesenchymal transition (EndoMT) |
| Key regulators | Notch, TGF-beta, BMP, Wnt signaling; transcription factors Snail, Slug, Twist |
| Disease relevance | Congenital heart valve defects, bicuspid aortic valve, atrioventricular valve abnormalities |
What Is GO:0003199?
According to the Gene Ontology, GO:0003199 is defined as a transition where an endocardial cushion cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell that will contribute to the formation of a cardiac valve. In simpler terms, it is the process by which cells in the embryonic heart cushion change from a tightly bound sheet into free-moving cells that build the valve leaflets.
Why Is endocardial cushion to mesenchymal transition involved in heart valve formation Important in Cell Biology?
GO:0003199 is critical because it is the cellular engine that builds the heart valves, and its failure causes congenital heart valve malformations, which are among the most common birth defects. Understanding this process provides insight into normal valve development and offers potential targets for regenerative medicine and for preventing valve disease progression.
• Essential for formation of atrioventricular and outflow tract valves.
• Defects lead to congenital heart valve anomalies such as bicuspid aortic valve.
• Involved in outflow tract septation, linking valve formation to septation defects.
• Regulated by hemodynamic forces, making it sensitive to mechanical environment.
• Modulated by microRNAs, providing post-transcriptional control.
• Requires coordinated signaling through Notch, TGF-beta, BMP and Wnt pathways.
• Serves as a paradigm for studying endothelial-to-mesenchymal transition in development and disease.
• Provides a model for understanding cell plasticity and migration.
• Relevant to tissue engineering of heart valves.
• A target for CRISPR-based functional genomics in cardiovascular research.
What Happens During endocardial cushion to mesenchymal transition involved in heart valve formation?
Initiation and signaling
In simple terms: Cells in the heart cushion receive signals that tell them to start changing.
The transition begins when endocardial cells overlying the cushion receive inductive signals from the myocardium, including Notch, TGF-beta, BMP and Wnt ligands. These signals activate transcription factors such as Snail, Slug and Twist, which drive the transition.
Loss of polarity and junctional disassembly
In simple terms: The cells lose their sense of direction and detach from each other.
Endocardial cushion cells lose apical/basolateral polarity and sever intercellular adhesive junctions, a hallmark of the transition. This step is accompanied by changes in adhesion molecule expression, including downregulation of VE-cadherin.
Basement membrane degradation and invasion
In simple terms: The cells break down the surrounding matrix and start moving.
The cells degrade basement membrane components through matrix metalloproteinases and become migratory mesenchymal cells that invade the cushion matrix. This invasive behavior is essential for populating the valve primordia.
Migration and valve remodeling
In simple terms: The new mesenchymal cells move into the cushion and help shape the valve.
Migratory mesenchymal cells contribute to the formation of cardiac valve leaflets and are later remodeled into mature valve structures. Disruption of this step leads to valve malformations.
Regulation by hemodynamics and microRNAs
In simple terms: Blood flow and small RNA molecules fine-tune the process.
Increased hemodynamic load alters the transition, and microRNAs such as miR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular cushion formation. These regulatory layers ensure proper timing and extent of the transition.
Key Genes Involved in GO:0003199 endocardial cushion to mesenchymal transition involved in heart valve formation
The following genes and proteins are central to GO:0003199, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Signaling receptor that initiates EndoMT | Mutations linked to bicuspid aortic valve |
| TGFB1 | Induces EndoMT via Smad signaling | Key regulator of cushion formation |
| BMP2 | Promotes EndoMT and cushion development | Essential for valve formation |
| SNAI1 | Transcription factor driving EMT | Master regulator of EndoMT |
| SNAI2 | Transcription factor promoting cell migration | Modulates EndoMT |
| TWIST1 | Transcription factor involved in EMT | Regulates cell plasticity |
| CDH5 | Endothelial adhesion molecule | Downregulated during EndoMT |
| MMP2 | Matrix metalloproteinase | Degrades basement membrane |
| MMP9 | Matrix metalloproteinase | Facilitates invasion |
| VIM | Mesenchymal marker | Upregulated in transitioning cells |
| ACTA2 | Smooth muscle actin | Marker of mesenchymal cells |
| MIR23B | MicroRNA regulating EMT | Impairs EndoMT |
| MIR199A | MicroRNA regulating EMT | Impairs EndoMT |
| MFNG | Manic Fringe, Notch modulator | Promotes EndoMT via Notch |
| GATA4 | Transcription factor | Regulates valve development |
| NKX2-5 | Transcription factor | Early cardiac development |
| TBX20 | Transcription factor | Valve morphogenesis |
How Is endocardial cushion to mesenchymal transition involved in heart valve formation Regulated?
The transition is regulated by multiple signaling pathways and transcription factors. Notch signaling, modulated by Manic Fringe, promotes EndoMT. TGF-beta and BMP pathways activate Smad-dependent transcription. Hemodynamic forces alter the transition, with increased load affecting EndoMT. MicroRNAs miR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular cushion formation. These layers of regulation ensure proper valve development.
endocardial cushion to mesenchymal transition involved in heart valve formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | Bicuspid aortic valve | Knockout mouse, iPSC-derived endothelial cells |
| TGFB1 | Valve malformations | Conditional knockout mouse |
| BMP2 | Congenital heart defects | Zebrafish knockout |
| SNAI1 | Valve dysplasia | Overexpression mouse model |
| MIR23B | Impaired EndoMT | miRNA mimic in chick embryos |
Congenital heart valve malformations
Defects in GO:0003199 cause congenital heart valve anomalies, including bicuspid aortic valve and atrioventricular valve abnormalities. Disruption of EndoMT underlies outflow tract septation defects and bicuspid aortic valve formation in animal models.
Bicuspid aortic valve
Endocardial-to-mesenchymal transition underlies cardiac outflow tract septation and bicuspid aortic valve formation, as shown in the Syrian hamster model. This highlights the clinical relevance of the transition to valve disease.
Atrioventricular valve abnormalities
Molecular mechanisms underlying morphogenesis of atrioventricular valves are linked to EndoMT, and their disruption leads to clinical abnormalities.
From endocardial cushion to mesenchymal transition involved in heart valve formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive EndoMT? | CRISPR knockout in mouse endocardial cells |
| Does point mutation in gene Y affect valve formation? | Knock-in mouse with point mutation |
| Can overexpression of gene Z rescue EndoMT? | Transgenic overexpression mouse |
| Where is protein X localized during EndoMT? | Tagged knock-in (e.g., GFP) mouse |
| What is the transcriptional profile of transitioning cells? | RNA-seq of sorted cushion cells |
| Does miRNA M regulate EndoMT? | miRNA knockout or mimic in zebrafish |
How to Study the endocardial cushion to mesenchymal transition involved in heart valve formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| En face preparation | Cell morphology and planar polarity | Mouse embryo cushion analysis |
| RNA-seq | Transcriptional changes | Identifying regulators of EndoMT |
| Lineage tracing | Cell fate | Tracking endocardial to mesenchymal conversion |
| Immunofluorescence | Protein localization | Detecting Snail, VE-cadherin |
| Collagen invasion assay | Invasive capacity | Functional assessment of EndoMT |
| miRNA mimic/inhibitor | Post-transcriptional regulation | Testing miR-23b/199a effects |
| Hemodynamic loading | Mechanical effects | Altering EndoMT in chick embryos |
En face endocardial cushion preparation
This technique allows planar morphogenesis analysis in mouse embryos, enabling visualization of cell shape changes during EndoMT.
Lineage tracing and imaging
Genetic lineage tracing combined with confocal imaging tracks the fate of endocardial cells as they transition to mesenchymal cells.
Transcriptomics
RNA-seq of isolated cushion cells reveals gene expression changes during EndoMT.
Functional assays
Collagen gel invasion assays and scratch wound assays measure migratory capacity of transitioning cells.
How CRISPR Can Be Used to Study GO:0003199 endocardial cushion to mesenchymal transition involved in heart valve formation
Knockout
CRISPR knockout of candidate genes such as NOTCH1 or SNAI1 in mouse endocardial cells can test their requirement for EndoMT.
Point Mutation
Knock-in of disease-associated point mutations (e.g., in NOTCH1) allows assessment of their impact on valve formation.
Knock-in
Tagged knock-in (e.g., GFP) enables live imaging of protein localization during EndoMT.
Overexpression
CRISPR activation or transgenic overexpression can test sufficiency of genes like TGFB1 in driving EndoMT.
How EDITGENE Supports endocardial cushion to mesenchymal transition involved in heart valve formation Research
Researchers studying endocardial cushion to mesenchymal transition involved in heart valve formation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides CRISPR-based services to enable such causal tests.
Contact EDITGENE today to design your custom CRISPR model for endocardial cushion to mesenchymal transition involved in heart valve formation research.
Frequently Asked Questions About endocardial cushion to mesenchymal transition involved in heart valve formation
What is GO:0003199?
GO:0003199 is the Gene Ontology term for endocardial cushion to mesenchymal transition involved in heart valve formation, a process where endocardial cushion cells become migratory mesenchymal cells that build cardiac valves.
What genes are involved in endocardial cushion to mesenchymal transition?
Key genes include NOTCH1, TGFB1, BMP2, SNAI1, SNAI2, TWIST1, and microRNAs such as miR-23b and miR-199a.
How is endocardial cushion to mesenchymal transition regulated?
It is regulated by Notch, TGF-beta, BMP and Wnt signaling, transcription factors, hemodynamic forces, and microRNAs.
What diseases are associated with defects in this process?
Defects cause congenital heart valve malformations, including bicuspid aortic valve and atrioventricular valve abnormalities.
What methods are used to study endocardial cushion to mesenchymal transition?
Methods include en face cushion preparation, lineage tracing, RNA-seq, immunofluorescence, and invasion assays.
What is the role of Notch signaling in this process?
Notch signaling, modulated by Manic Fringe, promotes endothelial-to-mesenchymal transition during heart valve development.
How do microRNAs affect endocardial cushion to mesenchymal transition?
miR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation.
Can CRISPR be used to study this process?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of genes in EndoMT.
What is the difference between EndoMT and EMT?
EndoMT is a specialized form of epithelial-to-mesenchymal transition occurring in endothelial cells during heart valve formation.
Why is hemodynamic load important for this transition?
Increased hemodynamic load in early embryonic stages alters endocardial to mesenchymal transition, affecting valve development.
Conclusion
GO:0003199 is a fundamental biological process that drives heart valve formation through endothelial-to-mesenchymal transition. Its dysregulation leads to congenital valve defects, making it a critical area of research. CRISPR-based models offer powerful tools to dissect the genetic and molecular mechanisms underlying this transition.
References
- 1. Wang J et al.. 2026. The regulation of endothelial-to-mesenchymal transition in endocardial cushion development: Signaling pathways and transcription factors.. Differentiation 151:100987 PMID: 42600378
- 2. Soto-Navarrete MT et al.. 2025. Endocardial-to-mesenchymal transition underlies cardiac outflow tract septation and bicuspid aortic valve formation in the Syrian hamster model.. Sci Rep 15(1):8583 PMID: 40074779
- 3. Midgett M et al.. 2017. Increased Hemodynamic Load in Early Embryonic Stages Alters Endocardial to Mesenchymal Transition.. Front Physiol 8:56 PMID: 28228731
- 4. Gonzalez-Costa T et al.. 2022. En Face Endocardial Cushion Preparation for Planar Morphogenesis Analysis in Mouse Embryos.. J Vis Exp PMID: 35969077
- 5. Yang J et al.. 2025. Manic Fringe promotes endothelial-to-mesenchymal transition mediated by the Notch signalling pathway during heart valve development.. J Mol Med (Berl) 103(1):51-71 PMID: 39528804
- 6. Person AD et al.. 2005. Cell biology of cardiac cushion development.. Int Rev Cytol 243:287-335 PMID: 15797462
- 7. Bonet F et al.. 2015. MiR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation.. Dev Dyn 244(10):1259-75 PMID: 26198058
- 8. Nakanishi T et al.. 2016. Atrioventricular Valve Abnormalities: From Molecular Mechanisms Underlying Morphogenesis to Clinical Perspective.. PMID: 29787116
